Monitoring and screening COPD in community pharmacies: experimentation in Italy

被引:0
作者
Baratta, Francesca [1 ]
Pignata, Irene [1 ]
Onorati, Roberta [2 ]
Gnavi, Roberto [2 ]
Costa, Giuseppe [2 ,3 ]
Brusa, Paola [1 ]
Spadea, Teresa [2 ]
机构
[1] Univ Turin, Dept Drug Sci & Technol, Turin, Italy
[2] ASL TO3, Epidemiol Unit, Grugliasco, Piedmont Region, Italy
[3] Univ Turin, Dept Clin & Biol Sci, Turin, Italy
来源
PHARMACY PRACTICE-GRANADA | 2023年 / 21卷 / 03期
关键词
community pharmacy; adherence; case finding; counselling; COPD; OBSTRUCTIVE PULMONARY-DISEASE; PHARMACEUTICAL CARE; MANAGEMENT; ADHERENCE; IMPACT; ASTHMA; UNDERTREATMENT; NONADHERENCE; THERAPIES; URBAN;
D O I
10.18549/PharmPract.2023.3.2854
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objective: COPD is one of the most important causes of morbidity and mortality worldwide. The health and economic burden of COPD may in part be reduced by early disease case finding and a correct therapy. This study aimed to investigate the feasibility of a community pharmacy programme for COPD case finding among previously undiagnosed subjects and for monitoring and enhancing adherence to prescribed pharmacological therapies among patients with confirmed COPD. Methods: The intervention was conducted in hundred community pharmacies in Piedmont (northwest Italy) and developed in two different arms: a case finding one through the administration of a specific questionnaire and the spirometry measurement and the adherence one through the administration of a questionnaire exploring the impact of the disease and the therapy adherence. Persons considered at risk to develop the COPD disease or non-controlled patients were referred to the GP or were invited to return in the pharmacy for a follow-up interview. Results: Overall, 844 subjects, out of 934 enrolled, completed the baseline interview. 103 subjects (25.7% of the 401 enrolled in the case finding arm) were considered at risk of suffering from COPD. Lower educated subjects and those without social support were more frequently at very high risk. Five returned to the pharmacy with a confirmed medical diagnosis. Among the 443 patients interviewed we found non-adherence value (depending on the drug) varying from 31% to 46%. A significant protection from non-adherence to bronchodilators was found among patients with comorbidities and among people living alone. Conclusions: We showed that opportunistic screening for COPD is feasible in community pharmacies. Concerning adherence to therapy in pharmacies, it would be necessary to identify different methods of enrolment in order to involve only those patients who are less adherent or who have difficulties in the management of therapy and chronic pathology.
引用
收藏
页数:16
相关论文
共 62 条
  • [1] American Lung Association, COPD Prevalence
  • [2] [Anonymous], 2013, Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease, Updated
  • [3] [Anonymous], GLOBAL STRATEGY DIAG
  • [4] [Anonymous], 2012, International Standard Classification of Education: ISCED
  • [5] Perceived feasibility of a community pharmacy-based asthma intervention: a qualitative follow-up study
    Bereznicki, B.
    Peterson, G.
    Jackson, S.
    Walters, E. Haydn
    DeBoos, I.
    Hintz, P.
    [J]. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2011, 36 (03) : 348 - 355
  • [6] Geographic distribution of COPD prevalence in the world displayed by Geographic Information System maps
    Blanco, Ignacio
    Diego, Isidro
    Bueno, Patricia
    Casas-Maldonado, Francisco
    Miravitlles, Marc
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2019, 54 (01)
  • [7] Patient adherence in COPD
    Bourbeau, J.
    Bartlett, S. J.
    [J]. THORAX, 2008, 63 (09) : 831 - 838
  • [8] Self-medication for migraine: A nationwide cross-sectional study in Italy
    Brusa, Paola
    Allais, Gianni
    Scarinzi, Cecilia
    Baratta, Francesca
    Parente, Marco
    Rolando, Sara
    Gnavi, Roberto
    Spadea, Teresa
    Costa, Giuseppe
    Benedetto, Chiara
    Mana, Massimo
    Giaccone, Mario
    Mandelli, Andrea
    Manzoni, Gian Camillo
    Bussone, Gennaro
    [J]. PLOS ONE, 2019, 14 (01):
  • [9] Community pharmacies as epidemiological sentinels of headache: first experience in Italy
    Brusa, Paola
    Parente, Marco
    Allais, Gianni
    Rolando, Sara
    Costa, Giuseppe
    Gnavi, Roberto
    Spadea, Teresa
    Giaccone, Mario
    Mandelli, Andrea
    Mana, Massimo
    Baratta, Francesca
    Benedetto, Chiara
    Bussone, Gennaro
    [J]. NEUROLOGICAL SCIENCES, 2017, 38 : S15 - S20
  • [10] Health and social impacts of COPD and the problem of under-diagnosis
    Carlone, Stefano
    Balbi, Bruno
    Bezzi, Michela
    Brunori, Marco
    Calabro, Stefano
    Barbaro, Maria Pia Foschino
    Micheletto, Claudio
    Privitera, Salvatore
    Torchio, Roberto
    Schino, Pietro
    Vianello, Andrea
    [J]. MULTIDISCIPLINARY RESPIRATORY MEDICINE, 2014, 9